M. Monzo, MD, PhD | Authors

Novel Approaches in the Treatment of Non-Small-Cell Lung Cancer

March 03, 2001

A wealth of data indicates that certain genetic abnormalities can target specific cytotoxic drugs and intervene at an early step as a mechanism of resistance in the treatment of non-small-cell lung cancer. Therefore prescribing